Acorn Wealth Advisors, LLC Amgen Inc Transaction History

Acorn Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $40,207 - $45,329	-217 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $166 - $186	1 Added 0.46%	217 $40,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $38,291 - $44,748	-226 Reduced 51.13%	216 $38,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $74,605 - $83,356	442	442 $80,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Acorn Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Acorn Wealth Advisors, LLC with notifications on news.